These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Rivera JA; Fernández-del Castillo C; Pins M; Compton CC; Lewandrowski KB; Rattner DW; Warshaw AL Ann Surg; 1997 Jun; 225(6):637-44; discussion 644-6. PubMed ID: 9230804 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas. Swartz MJ; Hsu CC; Pawlik TM; Winter J; Hruban RH; Guler M; Schulick RD; Cameron JL; Laheru DA; Wolfgang CL; Herman JM Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):839-44. PubMed ID: 19647950 [TBL] [Abstract][Full Text] [Related]
26. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961 [TBL] [Abstract][Full Text] [Related]
27. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296 [TBL] [Abstract][Full Text] [Related]
29. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637 [TBL] [Abstract][Full Text] [Related]
30. Significance of aggressive surgery for an invasive carcinoma derived from an intraductal papillary mucinous neoplasm diagnosed preoperatively as borderline resectable. Aimoto T; Mizutani S; Kawano Y; Suzuki H; Uchida E J Nippon Med Sch; 2013; 80(5):371-7. PubMed ID: 24189355 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Matthaei H; Norris AL; Tsiatis AC; Olino K; Hong SM; dal Molin M; Goggins MG; Canto M; Horton KM; Jackson KD; Capelli P; Zamboni G; Bortesi L; Furukawa T; Egawa S; Ishida M; Ottomo S; Unno M; Motoi F; Wolfgang CL; Edil BH; Cameron JL; Eshleman JR; Schulick RD; Maitra A; Hruban RH Ann Surg; 2012 Feb; 255(2):326-33. PubMed ID: 22167000 [TBL] [Abstract][Full Text] [Related]
32. Patterns of Recurrence After Resection of IPMN: Who, When, and How? Marchegiani G; Mino-Kenudson M; Ferrone CR; Morales-Oyarvide V; Warshaw AL; Lillemoe KD; Castillo CF Ann Surg; 2015 Dec; 262(6):1108-14. PubMed ID: 25793719 [TBL] [Abstract][Full Text] [Related]
33. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Murakami Y; Uemura K; Ohge H; Hayashidani Y; Sudo T; Sueda T Surgery; 2006 Sep; 140(3):448-53. PubMed ID: 16934608 [TBL] [Abstract][Full Text] [Related]
37. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416 [TBL] [Abstract][Full Text] [Related]
38. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847 [TBL] [Abstract][Full Text] [Related]
39. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas. Saito M; Imada H; Suzuki T; Sata N; Yasuda Y; Maetani I; Fukushima N Ann Diagn Pathol; 2015 Oct; 19(5):347-52. PubMed ID: 26265194 [TBL] [Abstract][Full Text] [Related]
40. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]